IT8720698A0 - Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer. - Google Patents

Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.

Info

Publication number
IT8720698A0
IT8720698A0 IT8720698A IT2069887A IT8720698A0 IT 8720698 A0 IT8720698 A0 IT 8720698A0 IT 8720698 A IT8720698 A IT 8720698A IT 2069887 A IT2069887 A IT 2069887A IT 8720698 A0 IT8720698 A0 IT 8720698A0
Authority
IT
Italy
Prior art keywords
adaptivity
treatment
pharmaceutical composition
senile dementia
alzheimer type
Prior art date
Application number
IT8720698A
Other languages
English (en)
Other versions
IT1205042B (it
Inventor
Umberto Cornelli
Thomas A Ban
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to IT20698/87A priority Critical patent/IT1205042B/it
Publication of IT8720698A0 publication Critical patent/IT8720698A0/it
Priority to US07/197,419 priority patent/US4956347A/en
Priority to ES198888201047T priority patent/ES2040323T3/es
Priority to DE8888201047T priority patent/DE3865099D1/de
Priority to AT88201047T priority patent/ATE67666T1/de
Priority to EP88201047A priority patent/EP0293974B1/en
Priority to JP63128581A priority patent/JPS6419021A/ja
Application granted granted Critical
Publication of IT1205042B publication Critical patent/IT1205042B/it
Priority to GR91401381T priority patent/GR3002802T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IT20698/87A 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer IT1205042B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US07/197,419 US4956347A (en) 1987-05-28 1988-05-23 Use of sulfomucopolysaccharides in the treatment of Alzheimer-type senile dementia
ES198888201047T ES2040323T3 (es) 1987-05-28 1988-05-24 Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.
DE8888201047T DE3865099D1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
AT88201047T ATE67666T1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
EP88201047A EP0293974B1 (en) 1987-05-28 1988-05-24 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia
JP63128581A JPS6419021A (en) 1987-05-28 1988-05-27 Use of sulfomco polysaccharides for therapeutically treating alzheimer's senile dementia
GR91401381T GR3002802T3 (en) 1987-05-28 1991-09-26 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Publications (2)

Publication Number Publication Date
IT8720698A0 true IT8720698A0 (it) 1987-05-28
IT1205042B IT1205042B (it) 1989-03-10

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Country Status (8)

Country Link
US (1) US4956347A (it)
EP (1) EP0293974B1 (it)
JP (1) JPS6419021A (it)
AT (1) ATE67666T1 (it)
DE (1) DE3865099D1 (it)
ES (1) ES2040323T3 (it)
GR (1) GR3002802T3 (it)
IT (1) IT1205042B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
ATE94384T1 (de) * 1989-04-14 1993-10-15 Merz & Co Gmbh & Co Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
EP1060750B1 (en) * 1993-03-29 2005-12-07 Queen's University At Kingston Propane-1,3-disulfonic acid and its pharmaceutically acceptable salts for treating amyloidosis
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
WO1998001101A2 (en) 1996-07-09 1998-01-15 Crutcher Keith A Methods for the treatment of apolipoprotein e related diseases
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
JP4659209B2 (ja) * 1997-08-28 2011-03-30 ユニバーシティ・オブ・ワシントン アルツハイマー病および他のアミロイド症を治療するための特定の糖組成物
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
US20060183800A1 (en) * 2004-11-12 2006-08-17 Xianqi Kong Methods and fluorinated compositions for treating amyloid-related diseases
US20060167057A1 (en) * 2004-11-16 2006-07-27 Xianqi Kong Compounds for the treatment of CNS and amyloid associated diseases
CA2592320C (en) * 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
ES2352801T3 (es) * 2005-12-22 2011-02-23 Kiacta Sàrl Tratamiento de nefropatía diabética.
CA2666246C (en) 2006-10-12 2013-12-31 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
MX2009006768A (es) * 2006-12-22 2009-08-31 Bellus Health Int Ltd Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
US20170100428A1 (en) * 2014-05-30 2017-04-13 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
GR3002802T3 (en) 1993-01-25
EP0293974A1 (en) 1988-12-07
DE3865099D1 (de) 1991-10-31
IT1205042B (it) 1989-03-10
US4956347A (en) 1990-09-11
EP0293974B1 (en) 1991-09-25
ATE67666T1 (de) 1991-10-15
JPS6419021A (en) 1989-01-23
ES2040323T3 (es) 1993-10-16

Similar Documents

Publication Publication Date Title
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
IT1234215B (it) Forma di dosaggio per il trattamento di malattie cardiovascolari
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
PT88423A (pt) Process for the preparation of oxadiazolyl-azabicycloheptanes for the treatment of senile dementia
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IT8720181A0 (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata.
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
GB2216412B (en) Interleukin-6 molecule for the treatment of bone-related diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
IT1224741B (it) Dispositivo per il trattamento delle malattie delle gengive
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT8848258A0 (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
ITMI911095A0 (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
IE890271L (en) Drugs for the treatment of senile dementia
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ITMI930966A0 (it) Composizioni farmaceutiche per il trattamento della psoriasi
IT8819400A0 (it) Composizioni aminoacidiche perfezionate per il trattamento specifico delle insufficienze multiple d'organo.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960509